Sophiris Bio Inc T.SHS

Primary Symbol: SPHS

Healthcare Biotechnology

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is a genetically modified recombinant protein which is selectively activated by enzymatically active prostate-specific antigen (PSA), which is only present in the prostate, leading to localized cell death and tissue disruption without damage to neighboring tissue and nerves. Geographically all the operations of the company are functioned in the United States.

EXPM:SPHS - Post by User

Sophiris Bio Inc

Bullboard Posts

Comment by rythmanon Jun 16, 2014 12:36pm

139 Views

Post# 22663572

RE:Loss ??

ya, I know how you feel, it's just that they bought in recently and were willilng to pay $3.31 for a reason. I'm surprised that the share price drifted this low. Does anyone know who Leerink is?
rythman

Bullboard Posts

Investing with insurance and protection